Search
for
Sort by
Research 931–960 of 1000+
- Treatment options for alopecia: an update, looking to the future
- Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome
- Immunomodulators in the treatment of cutaneous lymphoma
- Aldesleukin
- 068 Pathogenic Th17 cells, CD8+CD69+CD49a- tissue-resident memory T cells and common γ chain receptor + natural killer cells express more IL-17, compared to IFN-γ, under the foxp3+ memory regulatory T cells-depleted microenvironment in patients with chronic alopecia areata
- Satoyoshi syndrome: A rare multisystemic disorder requiring systemic and symptomatic treatment
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- 083 More Expression of IL-17 than IFN-γ from CD49a-negative Tissue-Resident Memory T (Trm) cells at the Hair Bulge and Hair Bulb Region in the Scalp of Chronic Alopecia Areata Patients according to the Foxp3+mTregs depletion
- 080 Mouse models of alopecia areata: C3H/HeJ mice versus the humanized AA mouse model
- Hair-growth promoting effect and anti-inflammatory mechanism of Ginkgo biloba polysaccharides
- Conjoint analysis of methylation, transcriptomic, and proteomic profiles in pemphigus vulgaris
- Unveiling the Effect of Age and IgE Level on Alopecia Areata: Insights from Comparative RNAseq Analysis
- Vitiligo: Clinical and Laboratory Characteristics in 573 Saudi Patients.
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- IL-3 contributes to development of lupus nephritis in MRL/Ipr mice
- An implication for post-transcriptional control: Reciprocal changes of melanocortin receptor type 2 mRNA and protein expression in alopecia areata
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Comprehensive single-cell transcriptomic profiling of the scalp from patients with moderate-to-severe alopecia areata
- Treatment of alopecia areata with JAK inhibitors
- 165 Single-cell RNA sequencing analysis unveils highly active yet diminished CD14+CD16- circulating monocytes, independent of alopecia areata severity
- Lymphocytes, neuropeptides, and genes involved in alopecia areata
- Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies
- Excimer Laser: A Module of the Alopecia Areata Common Protocol
- RETRACTED: Serum lipids may causally affect the occurrence of alopecia areata: A Mendelian randomization study
- Evaluating the Causal Relationship Between Human Blood Metabolites and the Susceptibility to Alopecia Areata
- Interleukin-15 is a hair follicle immune privilege guardian
- Exploring differential gene expression and biomarker potential in systemic lupus erythematosus: a retrospective study
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- 319 Novel Circulating Natural Killer Cell Subset as Biomarkers in Alopecia Areata Progression